MTD at a glance
Mettler Toledo (MTD, SEC CIK 1037646) filed its latest 10-K annual report on February 6, 2026, a 10-Q quarterly report on November 6, 2026, an 8-K current report on November 5, 2026 and Form 4 insider filings as recently as November 16, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), Mettler Toledo (MTD) reported revenue of $4.0 billion (up 4.0% from FY2024) and net income of $869.2 million. Diluted EPS was $42.05.
- As of September 30, 2026, 37 institutional investment managers tracked by SignalX reported holding Mettler Toledo (MTD) shares worth $11.7 billion in 13F-HR filings.
- In the last 90 days, MTD insiders reported 0 open-market purchases ($0) and 3 open-market sales ($2.1M) on Form 4, a net sale of $2.1M.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $4.0B
- +4.0% vs prior year
- Insiders · 90 days
- 0 buys · 3 sells
- Net −$2.1M
- 13F holders
- 37 funds
- $11.7B · +0 vs prior quarter
- Latest 8-K
- Nov 5, 2026
- Item 2.02
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Dec 31, 2025
Risk Factors
- U.S.-China geopolitical tensions causing 16% sales, 29% segment profit, 29% production exposure in China with tariff increases and supply chain risks
- Ukraine war and Middle East conflict disrupting supply chains, increasing costs, reducing shipping capacity, and heightening global economic uncertainty
- Single-location manufacturing dependencies in China, Europe, and U.S. risking significant production disruptions from labor unrest, natural disasters, or cybersecurity attacks
- Competition from larger firms and emerging market low-cost competitors accelerating AI and digitalization adoption, pressuring margins and market share
- Currency risk with 1% Swiss franc strengthening estimated to reduce earnings before tax by $2.8-$3.1 million annually, and 5% USD weakening increasing debt by $53.7 million
Management Discussion & Analysis
- Revenue $4.0B in 2025, up 4% YoY from $3.9B in 2024; local currency sales up 3% in 2025 and 2024
- Gross margin 59.4% in 2025 vs 60.1% in 2024; product margin 61.1% vs 62.1%, service margin 54.4% vs 53.7%
- Best segment: U.S. Operations, sales $1.50B (+5%), profit $375M (-5%); Worst: Swiss Operations, sales $211M (-4%), profit $284M (+1%)
- R&D 5.0% of sales, SG&A 24.8%; Interest expense $68.5M (down); Restructuring charges $17.9M (down); acquisitions expanded service revenue by ~1%
- Management cites ongoing risks from tariffs ($50M costs in 2025), geopolitical uncertainty; growth drivers automation, digitalization, emerging markets
Business Overview
- Core business: Precision instruments and analytical equipment manufacturing for laboratory and industrial use
- New share repurchase program authorization of $2.75 billion in November 2025, adding to $3.7 billion remaining availability
- Share repurchase spending $800 million in 2025 on 646,608 shares at average $1,237.18 per share versus $850 million in 2024
- Total shares repurchased since 2004: 33.0 million at average price $320.91, cost $10.6 billion through 2025
- Inflation Reduction Act excise tax $7.4 million in 2025, slightly reducing shareholders' equity
AI summary of the MTD 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Sep 30, 2026
Risk Factors
- No material changes to previously disclosed risk factors for the three and nine months ended September 30, 2026
- Carried-forward risks remain those disclosed in the December 31, 2025 Form 10-K
Management Discussion & Analysis
- Revenue $1.094B, up 6% YoY from $1.030B
- Gross margin 59.8% vs 59.2% YoY, net earnings margin 22.5% vs 21.1%
- Chinese Operations strongest: sales $303.6M, up 19%; Food retailing weakest, sales down 1%
- Operating cash flow $758.8M for nine months vs $730.2M; share repurchases $638.7M
- Outlook: tariff changes, Iran conflict, Middle East uncertainty and inflation threaten demand and results
AI summary of the MTD 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 2.02: Results of Operations and Financial Condition
- Q3 and nine-month FY2026 results announced for periods ended September 30, 2026
- Key financial figures and management commentary reside in Exhibit 99.1, the accompanying earnings release
Item EX-99.1: Item EX-99.1
- Q3 sales $1.094B, up 6%; Asia/Rest of World led growth at 16%, versus 3% Americas and flat Europe
- Q3 diluted EPS $12.29, up from $10.57; adjusted EPS $12.57, up 13%, with adjusted operating margin 30.5%
Item 5.02: Departure/Appointment of Directors or Principal Officers
- Natalia Shuman appointed independent director effective August 3, 2026
- Board expanded from nine to ten directors, increasing governance capacity
Item 7.01: Regulation FD Disclosure
- Press release announces Ms. Shuman’s appointment, creating a management succession and leadership-change consideration
- Investors should review Exhibit 99.1 for her role, effective date and relevant qualifications
Item EX-99.1: Item EX-99.1
- Q2 sales $1.027B, up 4%; organic local-currency growth 4% excluding acquisitions and customer tariff refunds
- Adjusted EPS $11.46, up 14%; GAAP diluted EPS $11.55 versus $9.76
Item 2.02: Results of Operations and Financial Condition
- Q2 and first-half fiscal 2026 results announced for periods ended June 30, 2026
- Exhibit 99.1 contains the earnings release, including reported financial results and management commentary
AI summaries of MTD 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for MTD
Don't miss the next MTD filing
- Alerts as it files. A push when MTD files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut MTD, by share count.
- Ask anything. An AI agent that reads every MTD filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Keller Gerry | A | Nov 12, 2026 | 62 | - |
| Wong Ann Ping Richard | A | Nov 12, 2026 | 64 | - |
| Vadala Shawn | A | Nov 12, 2026 | 176 | - |
| Kaltenbach Patrick | A | Nov 12, 2026 | 534 | - |
| Wittorf Oliver | A | Nov 12, 2026 | 51 | - |
| SALICE THOMAS P | A | Nov 10, 2026 | 130 | - |
| Kaltenbach Patrick | A | Nov 10, 2026 | 496 | - |
| Zhang Ingrid | A | Nov 10, 2026 | 54 | - |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $3.9B | $4.0B |
| Gross Profit | $2.2B | $2.3B | $2.4B |
| Net Income | - | $863.1M | $869.2M |
| Gross Margin | - | 60.1% | 59.4% |
| Net Margin | - | 22.3% | 21.6% |
| Balance Sheet | |||
| Total Assets | $3.4B | $3.2B | $3.7B |
| Equity | - | -$126.9M | -$23.6M |
| ROE | - | -680.2% | -3677.4% |
| Per Share | |||
| EPS | $35.90 | $40.48 | $42.05 |
| Cash Flow | |||
| Operating CF | - | $968.3M | $955.8M |
| CapEx | $105.3M | $103.9M | $107.1M |
Source: XBRL data in Mettler Toledo (MTD)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q3 2026Aggregate MTD share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q3 2026 | 37 | $11.68B |
| Q2 2026 | 37 | $10.78B |
| Q1 2026 | 37 | $11.14B |
| Q4 2025 | 32 | $11.90B |
| Q3 2025 | 34 | $11.73B |
| Q2 2025 | 31 | $10.81B |
| Q1 2025 | 33 | $7.54B |
| Q4 2024 | 30 | $6.61B |
- Millennium Management+143.7K (+367%)
- Citadel Advisors LLC+118.3K (+682%)
- Morgan Stanley+44.5K (+10%)
- AQR Capital Management+20.3K (+16%)
- Vanguard Portfolio Management LLC+16.6K (+2%)
- BNY Mellon−305.2K (-51%)
- T. Rowe Price Group−270.6K (-86%)
- JPMorgan Chase & Co−124.4K (-56%)
- Goldman Sachs Group−94.5K (-37%)
- Principal Financial Group−81.7K (-44%)
Source: 13F-HR filings on SEC EDGAR (aggregated from 271 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
MTD filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Nov 16, 2026 | - | - | - |
| 4 | Nov 16, 2026 | - | - | - |
| 4 | Nov 16, 2026 | - | - | - |
| 4 | Nov 16, 2026 | - | - | - |
| 4 | Nov 16, 2026 | - | - | - |
| 4 | Nov 12, 2026 | - | - | - |
| 4 | Nov 12, 2026 | - | - | - |
| 4 | Nov 12, 2026 | - | - | - |
| 4 | Nov 12, 2026 | - | - | - |
| 4 | Nov 12, 2026 | - | - | - |
| 4 | Nov 12, 2026 | - | - | - |
| 4 | Nov 12, 2026 | - | - | - |
| 4 | Nov 12, 2026 | - | - | - |
| 4 | Nov 12, 2026 | - | - | - |
| 4 | Nov 12, 2026 | - | - | - |
| 4 | Nov 12, 2026 | - | - | - |
| 4 | Nov 12, 2026 | - | - | - |
| 4 | Nov 12, 2026 | - | - | - |
| 4 | Nov 12, 2026 | - | - | - |
| 4 | Nov 12, 2026 | - | - | - |
| 4 | Nov 12, 2026 | - | - | - |
| 4 | Nov 10, 2026 | - | - | - |
| 10-Q | Nov 6, 2026 | Sep 30, 2026 | Analysis | |
| 8-K | Nov 5, 2026 | - | Analysis | - |
| 4 | Sep 1, 2026 | - | - | - |
Related Health Care companies
- TXG · 10x Genomics, Inc.Laboratory Analytical Instruments
- A · Agilent TechnologiesLaboratory Analytical Instruments
- ALMR · Alamar Biosciences IncLaboratory Analytical Instruments
- AVTR · Avantor IncLaboratory Analytical Instruments
- BIO · Bio-rad Laboratories IncLaboratory Analytical Instruments
- BRKR · Bruker CorpLaboratory Analytical Instruments
- CTKB · Cytek Biosciences, Inc.Laboratory Analytical Instruments
- EYPT · EyePoint, Inc.Laboratory Analytical Instruments
MTD SEC filings: frequently asked questions
Are MTD insiders buying or selling?
In the last 90 days, Mettler Toledo (MTD) officers, directors and 10% owners reported no open-market purchases and 3 open-market sales worth $2.1 million by 2 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold MTD stock?
As of September 30, 2026, the largest Mettler Toledo (MTD) holders among the 13F filers tracked by SignalX were BlackRock ($2.7 billion), Vanguard Capital Management LLC ($2.0 billion), Vanguard Portfolio Management LLC ($1.6 billion), State Street Corp ($1.4 billion), Morgan Stanley ($770.1 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was MTD's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), Mettler Toledo (MTD) reported revenue of $4.0 billion (up 4.0% from FY2024) and net income of $869.2 million. Diluted EPS was $42.05. The figures come from the XBRL data in the 10-K.
What are the main risks in MTD's latest 10-K?
In the 10-K filed February 6, 2026, Mettler Toledo (MTD) flagged: U.S.-China geopolitical tensions causing 16% sales, 29% segment profit, 29% production exposure in China with tariff increases and supply chain risks. Ukraine war and Middle East conflict disrupting supply chains, increasing costs, reducing shipping capacity, and heightening global economic uncertainty. (AI summary of the Risk Factors section.)
What did MTD report in its latest 8-K?
Mettler Toledo (MTD) filed an 8-K on November 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q3 and nine-month FY2026 results announced for periods ended September 30, 2026.
What are the latest MTD SEC filings?
Mettler Toledo (MTD) filed its latest 10-K annual report on February 6, 2026, a 10-Q quarterly report on November 6, 2026, an 8-K current report on November 5, 2026 and a Form 4 insider filing on November 16, 2026.
What is MTD's SEC CIK number?
Mettler Toledo (MTD)'s SEC Central Index Key (CIK) is 1037646. EDGAR lists every MTD filing under that number.
Ask anything about MTD
The research agent reads MTD's filings, financials, insider trades and 13F holders, then answers with sources.